You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

Butoconazole nitrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for butoconazole nitrate and what is the scope of patent protection?

Butoconazole nitrate is the generic ingredient in four branded drugs marketed by Padagis Us, Roche Palo, Bayer, and Padagis Israel, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for butoconazole nitrate. One supplier is listed for this compound.

Summary for butoconazole nitrate
US Patents:0
Tradenames:4
Applicants:4
NDAs:5
Drug Master File Entries: 5
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 105
Clinical Trials: 4
Patent Applications: 1,435
What excipients (inactive ingredients) are in butoconazole nitrate?butoconazole nitrate excipients list
DailyMed Link:butoconazole nitrate at DailyMed
Recent Clinical Trials for butoconazole nitrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 2
Perrigo CompanyN/A
Padagis LLCN/A

See all butoconazole nitrate clinical trials

Pharmacology for butoconazole nitrate
Drug ClassAzole Antifungal

US Patents and Regulatory Information for butoconazole nitrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo FEMSTAT butoconazole nitrate CREAM;VAGINAL 019215-001 Nov 25, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer FEMSTAT 3 butoconazole nitrate CREAM;VAGINAL 020421-001 Dec 21, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Israel GYNAZOLE-1 butoconazole nitrate CREAM;VAGINAL 200923-001 May 18, 2012 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us BUTOCONAZOLE NITRATE butoconazole nitrate CREAM;VAGINAL 019881-001 Feb 7, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche Palo FEMSTAT butoconazole nitrate SUPPOSITORY;VAGINAL 019359-001 Nov 25, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for butoconazole nitrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Padagis Us BUTOCONAZOLE NITRATE butoconazole nitrate CREAM;VAGINAL 019881-001 Feb 7, 1997 ⤷  Sign Up ⤷  Sign Up
Padagis Us BUTOCONAZOLE NITRATE butoconazole nitrate CREAM;VAGINAL 019881-001 Feb 7, 1997 ⤷  Sign Up ⤷  Sign Up
Roche Palo FEMSTAT butoconazole nitrate CREAM;VAGINAL 019215-001 Nov 25, 1985 ⤷  Sign Up ⤷  Sign Up
Roche Palo FEMSTAT butoconazole nitrate SUPPOSITORY;VAGINAL 019359-001 Nov 25, 1985 ⤷  Sign Up ⤷  Sign Up
Padagis Us BUTOCONAZOLE NITRATE butoconazole nitrate CREAM;VAGINAL 019881-001 Feb 7, 1997 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.